Morgan Stanley’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $12.4M | Buy |
|
|||||
|
2022
Q3 | $2.42M | Sell |
|
|||||
|
2022
Q2 | $3.18M | Sell |
|
|||||
|
2022
Q1 | $6.4M | Buy |
|
|||||
|
2021
Q4 | $5.39M | Buy |
|
|||||
|
2021
Q3 | $2.13M | Sell |
|
|||||
|
2021
Q2 | $5.46M | Buy |
|
|||||
|
2021
Q1 | $4.52M | Sell |
|
|||||
|
2020
Q4 | $8.12M | Buy |
|
|||||
|
2020
Q3 | $2.28M | Buy |
|
|||||
|
2020
Q2 | $1.86M | Sell |
|
|||||
|
2020
Q1 | $3.78M | Buy |
|
|||||
|
2019
Q4 | $578K | Sell |
|
|||||
|
2019
Q3 | $305K | Sell |
|
|||||
|
2019
Q2 | $673K | Buy |
|
|||||
|
2019
Q1 | $85K | Buy |
|
|||||
|
2018
Q4 | $21K | Sell |
|
|||||
|
2018
Q3 | $1.07M | Buy |
|
|||||
|
2018
Q2 | $431K | Buy |
|
|||||
|
2018
Q1 | $33K | Buy |
|
|||||
|
2017
Q4 | $9K | Sell |
|
|||||
|
2017
Q3 | $41K | Sell |
|
|||||
|
2017
Q2 | $37K | Sell |
|
|||||
|
2017
Q1 | $170K | Sell |
|
|||||
|
2016
Q4 | $410K | Buy |
|